San Antonio, Texas Clinical Trials

A listing of San Antonio, Texas clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 58 clinical trials
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

match treatment
platelet count
cancer therapy
recurrent childhood rhabdomyosarcoma
radiopharmaceutical
Methodist Children's Hospital of South Texas
 (7.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +82 other locations
Multicenter Clinical Trial of a Phakic Implantable Collamer Lens (ICL)

This objective of this study is to evaluate the safety, and to collect supportive data on effectiveness of the EVO/EVO+ Visian Implantable Collamer Lens (ICL) in study participants who have a diagnosis of myopia or myopia with astigmatism. Primary study analysis will be evaluated when 300 primary eyes complete 6 …

myopia
severe myopia
astigmatism
Parkhurst NuVision
 (7.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +13 other locations
First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b

Phase 1b, a study in high grade serous ovarian cancer and nonsmall cell lung cancer to evaluate the safety and clinical activity of the antibody-drug conjugate (ADC) XMT-1592.

fallopian tube
measurable disease
hair thinning
cancer
solid tumour
NEXT Oncology
 (10.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
NBE-002 in Patients With Advanced Solid Tumors

This first-in-human study will evaluate the recommended dose for further clinical development, safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and pharmacodynamics of NBE-002, a novel anti-ROR1 antibody-drug conjugate, in patients with advanced solid tumors.

anthracycline
measurable disease
advanced solid tumor
solid neoplasm
blood coagulation tests
NEXT Oncology
 (7.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects

This is a randomized, single-blind, placebo-controlled, once daily (QD) dose study of CRV431 in presumed NASH F2/F3 subjects.

fibroscan
vcte
fatty liver
hepatic fibrosis
fibrosis
Quality Research Inc.
 (4.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations
Antibiotic Selection Using Next Generation Sequencing vs Urine Culture

This is a randomized controlled clinical study evaluating the use of next-generation sequencing (NGS) to improve antibiotic prescribing before ureteroscopy or percutaneous nephrolithotomy.

antibiotics
percutaneous nephrolithotomy
stone extraction
antibiotic therapy
nephrolithotomy
The University of Texas Health Science Center at San Antonio, Medical Arts and Research Center
 (7.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery

The overarching goal of the study is to improve the surgical treatment outcomes of FAI, which is affecting an increasing number of military personnel and young active individuals in the general population. The proposed study will investigate critical patient, disease, and surgical treatment predictors of FAI surgery outcomes.

hip arthroscopy
femoroacetabular impingement
conservative management
arthroscopy
San Antonio Military Medical Center
 (5.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +11 other locations
NCI COVID-19 in Cancer Patients NCCAPS Study

This study collects blood samples, medical information, and medical images from patients who are being treated for cancer and have a positive test for SARS CoV-2, the new coronavirus that causes the disease called COVID-19. Collecting blood samples, medical information, and medical images may help researchers determine how COVID-19 affects …

oropharyngeal
rituximab
monoclonal antibodies
bone marrow transplant
active treatment
University of Texas Health Science Center at San Antonio
 (7.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +575 other locations